asof | 2025-02-22

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) is a pharmaceutical company focused
on developing and commercializing innovative medicines for cancer and other
major diseases. The company's primary product is XPOVIO, a drug used to treat
multiple myeloma and other cancers. Karyopharm operates in a competitive
landscape alongside peers like MacroGenics, TG Therapeutics, Heron
Therapeutics, Intra-Cellular Therapies, and Agios Pharmaceuticals.
